A study in University College Cork wants to explore how people disclose their diagnosis of a long-term health condition. Can you help with this research?
These are a few tips for people living with epilepsy and their families to remember during this warm and sunny weather.
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee recently decided to keep the precautionary safety measures associated with Sodium Valproate treatment in men. Read more about the measures here.
We are looking forward to working with colleagues in FutureNeuro on the EPI-SLEEP study, which will evaluate the use of sleep technology in adults with epilepsy.
If you or a loved one are taking the Anti Seizure Medication, Ontozry, please familiarise yourself with important new safety measures associated with the medication following the emergence of new data.
Good luck to the Leaving Cert class of 2026!
Epilepsy Ireland addresses Sodium Valproate inquiry
It's the last week for nominations for the AIB Community Fund and we'd really appreciate your support to be in with a chance of potentially receiving funding of up to €20,000!
This week is National Epilepsy Week and is an important week for Epilepsy Ireland to raise awareness of epilepsy and share the realties of life with the condition.
Across the week on our website and social media channels, we will be sharing stories from people living with epilepsy and their key messages about the condition to the wider public, and the epilepsy community. You can read some of the stories we have received as part of the week below:
A new study from University College Cork is seeking to gain a greater understanding of the experience of medication-related care for people who attend hospital outpatient services.
Want the latest epilepsy & Epilepsy Ireland news straight to your inbox?
Keep in touch and sign up for our monthly email update!